Atlas Trials

Celregen Therapeutics

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Celregen Therapeutics

RecordFirmDate
An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events (NCT07503028)Celregen Therapeutics2025-10-17

Track Celregen Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.